pillbase.ru

CITOMIX

Wirkstoff: PINEAPPLE, LENOGRASTIM, CENTELLA ASIATICA, INTERFERON GAMMA-1B, CANAKINUMAB, ALDESLEUKIN, BINETRAKIN, HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED), SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE, SUS SCROFA BONE MARROW, CRANBERRY, SUS SCROFA THYMUS

Pellets [Übersetzung der Form; Original: PELLET (openFDA)] · PINEAPPLE 3 [hp_X]/4g, LENOGRASTIM 4 [hp_C]/4g, CENTELLA ASIATICA 3 [hp_X]/4g, INTERFERON GAMMA-1B 4 [hp_C]/4g, CANAKINUMAB 5 [hp_C]/4g, ALDESLEUKIN 5 [hp_C]/4g, BINETRAKIN 4 [hp_C]/4g, HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) 7 [hp_C]/4g, SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE 4 [hp_C]/4g, SUS SCROFA BONE MARROW 4 [hp_C]/4g, CRANBERRY 3 [hp_X]/4g, SUS SCROFA THYMUS 4 [hp_C]/4g

Vereinigte StaatenAktiv

Zulassungsinhaber: Guna spa

Geprüft 2026-10-09 · openFDA NDC

Zusammensetzung
  • PINEAPPLE · 3 [hp_X]/4g
  • LENOGRASTIM · 4 [hp_C]/4g
  • CENTELLA ASIATICA · 3 [hp_X]/4g
  • INTERFERON GAMMA-1B · 4 [hp_C]/4g
  • CANAKINUMAB · 5 [hp_C]/4g
  • ALDESLEUKIN · 5 [hp_C]/4g
  • BINETRAKIN · 4 [hp_C]/4g
  • HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) · 7 [hp_C]/4g
  • SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE · 4 [hp_C]/4g
  • SUS SCROFA BONE MARROW · 4 [hp_C]/4g
  • CRANBERRY · 3 [hp_X]/4g
  • SUS SCROFA THYMUS · 4 [hp_C]/4g
Zulassung
Zulassungsnummer
17089-076
Zulassungsstatus
Aktiv
Abgabe
Rezeptfrei
Art der Anwendung
ORAL
Quellen